MCM
PBH icon

Matarin Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Matarin Capital Management’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,507
Closed -$250K – 247
2016
Q2 		$250K Sell
4,507
-1,834
-29% -$101K 0.03% 222
2016
Q1 		$339K Sell
6,341
-48,979
-89% -$2.41M 0.05% 207
2015
Q4 		$2.85M Buy
55,320
+10,179
+23% +$506K 0.43% 104
2015
Q3 		$2.04M Buy
+45,141
New +$2.13M 0.42% 85

Other funds holding PBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
MRCP
Manor Road Capital Partners New York $63.8M AUM 19.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Matarin Capital Management's PBH Position: Q3 2016 in Review

Matarin Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q3 2016, closing a stake of 4,507 shares — an estimated $250K sold.

Matarin Capital Management first reported a position in PBH in Q3 2015 and held it in 4 quarters. The position peaked at $2.85M in Q4 2015. 243 funds tracked by Wall St. Rank hold PBH as of Q3 2016.

  • Matarin Capital Management reported no remaining Prestige Consumer Healthcare position as of Q3 2016 after selling out during the quarter.
  • Matarin Capital Management sold 4,507 Prestige Consumer Healthcare shares in Q3 2016, an estimated $250K.
  • Matarin Capital Management first reported a position in Prestige Consumer Healthcare in Q3 2015 and held it in 4 quarters.
  • Matarin Capital Management's Prestige Consumer Healthcare position peaked at $2.85M in Q4 2015.
  • 243 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2016.

Based on Matarin Capital Management's 13F filing for Q3 2016, filed 9 Nov 2016.